Medication-Assisted Treatment for Opioid Addiction During Pregnancy (TIP 43, Chapter 13)

Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs (TIP 43)

About the Course:

Medication-Assisted Treatment for Opioid Addiction During Pregnancy (TIP 43, Chapter 14): Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs describes the complications associated with pregnancy and opioid addiction and how pregnancy should be addressed to prevent the potential of harm to a pregnant woman in MAT and her fetus. This chapter relates how to adjust methadone dosage and withdrawal and addresses the postpartum treatment of both mother and child, which includes topics such as breast feeding and neonatal abstinence syndrome.

Course materials are from Chapter 13. Course materials can be accessed either 1) online or 2) by ordering the book free of charge from: http://store.samhsa.gov/product/TIP-43-Medication-Assisted-Treatment-for-Opioid-Addiction-in-Opioid-Treatment-Programs/SMA12-4214

Course materials are from Chapter 13, found on pages 211 to 224 of pdf document (pages 232 to 245 if using Adobe toolbar page finder).

Journal/Publisher:

SAMHSA

Publication Date:

Revised 2011

Author

U.S. Department of Health and Human Services

Recommended For:

This course is recommended for health care professionals, especially addiction counselors, psychologists, mental health counselors, and social workers who seek knowledge about medication-assisted treatment for opioid addiction during pregnancy. It is appropriate for all levels of participants’ knowledge.

Course Objectives:

  1. Evaluate medication-assisted treatment for opioid addiction during pregnancy, the acceptance of methadone maintenance as the standard of care, as well as the methadone dosage and management for pregnant women.

  2. Explain how to diagnose opioid addiction in pregnant patients and the medical and obstetrical concerns and complications that are associated with pregnancy.

  3. Acknowledge the postpartum treatment of mothers in MAT, effects of breast-feeding and neonatal outcome as well as the use of buprenorphine during pregnancy.

  4. Discuss the importance of integrated, comprehensive services and nutrition assessment.

Exam Questions

All exam questions for the course are visible on this page for members of Addiction Counselor CE.

Membership is free, and you can sign up today! You'll only pay when you're ready to purchase a course.

If you're already a member, please login to see the exam questions for this and all other courses.

Exam-related Actions